Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users-Reference-Cited by-同舟云学术

Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users

Published:2018-03-15 Issue:3 Volume:2018 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Baandrup Lone¹²,Ebdrup Bjørn H¹,Rasmussen Jesper Ø³⁴,Lindschou Jane⁵,Gluud Christian⁶,Glenthøj Birte Y¹

Affiliation:

1. Mental Health Centre Glostrup, Mental Health Services of the Capital Region; Centre for Neuropsychiatric Schizophrenia Research; Nordre Ringvej 29-67 Glostrup Denmark 2600

2. Mental Health Services of the Capital Region; Mental Health Centre Ballerup; Maglevaenget 2 Ballerup Denmark DK-2750

3. Mental Health Services of the Capital Region; Mental Health Centre Amager; Copenhagen Denmark

4. Mental Health Services of the Capital Region; Mental Health Centre Sct. Hans; Roskilde Denmark

5. Department 7812, Rigshospitalet, Copenhagen University Hospital; Copenhagen Trial Unit, Centre for Clinical Intervention Research; Blegdamsvej 9 Copenhagen Denmark DK-2100

6. Copenhagen Trial Unit, Centre for Clinical Intervention Research, Department 7812, Rigshospitalet, Copenhagen University Hospital; Cochrane Hepato-Biliary Group; Blegdamsvej 9 Copenhagen Denmark DK-2100

Publisher

Wiley

Subject

Pharmacology (medical)

Reference133 articles.

1. A double-blind placebo-controlled study of buspirone in diazepam withdrawal in chronic benzodiazepine users;Ashton;British Journal of Psychiatry,1990

2. Neurocognitive performance, subjective well-being, and psychosocial functioning after benzodiazepine withdrawal in patients with schizophrenia or bipolar disorder: a randomized clinical trial of add-on melatonin versus placebo;Baandrup;European Archives of Psychiatry and Clinical Neuroscience,2017

3. Objective and subjective sleep quality: melatonin versus placebo add-on treatment in patients with schizophrenia or bipolar disorder withdrawing from long-term benzodiazepine use;Baandrup;Psychiatry Research,2016

4. Prolonged-release melatonin versus placebo for benzodiazepine discontinuation in patients with schizophrenia or bipolar disorder: a randomised, placebo-controlled, blinded trial;Baandrup;World Journal of Biological Psychiatry,2016

5. A randomized, double-blind study of alpidem vs placebo in the prevention and treatment of benzodiazepine withdrawal syndrome;Cassano;European Psychiatry,1996

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Usage of sedatives for delirious patients and its ethical problems in ICU;Journal of the Japanese Society of Intensive Care Medicine;2024-09-01

2. Benzodiazepine Adverse Reaction Cases Age 50 and Older Reported to the U.S. Poison Centers: Healthcare Use and Major Medical Effects;Pharmacoepidemiology;2024-08-31

3. Evaluating drug withdrawal syndrome risks through food and drug administration adverse event reporting system: a comprehensive disproportionality analysis;Frontiers in Pharmacology;2024-07-10

4. Effective alleviation of depressive and anxious symptoms and sleep disorders in benzodiazepine‐dependent patients through repetitive transcranial magnetic stimulation;Addiction Biology;2024-07

5. Onset of Prolonged High-Potency Benzodiazepine Use Among ICU Survivors: A Nationwide Cohort Study;Critical Care Explorations;2024-07